22:32:19 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-20 Bokslutskommuniké 2024
2024-11-21 Kvartalsrapport 2024-Q3
2024-08-22 Kvartalsrapport 2024-Q2
2024-05-24 Ordinarie utdelning DIGN 0.00 SEK
2024-05-23 Årsstämma 2024
2024-05-23 Kvartalsrapport 2024-Q1
2024-03-12 Extra Bolagsstämma 2024
2024-02-15 Bokslutskommuniké 2023
2023-11-16 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-05-26 Ordinarie utdelning DIGN 0.00 SEK
2023-05-25 Kvartalsrapport 2023-Q1
2023-05-25 Årsstämma 2023
2023-02-16 Bokslutskommuniké 2022
2022-11-17 Kvartalsrapport 2022-Q3
2022-08-18 Kvartalsrapport 2022-Q2
2022-05-20 Ordinarie utdelning DIGN 0.00 SEK
2022-05-19 Årsstämma 2022
2022-05-19 Kvartalsrapport 2022-Q1
2022-02-17 Bokslutskommuniké 2021
2021-11-18 Kvartalsrapport 2021-Q3
2021-08-19 Kvartalsrapport 2021-Q2
2021-05-21 Ordinarie utdelning DIGN 0.00 SEK
2021-05-20 Årsstämma 2021
2021-05-20 Kvartalsrapport 2021-Q1
2021-02-18 Bokslutskommuniké 2020
2021-01-11 Extra Bolagsstämma 2021
2020-11-19 Kvartalsrapport 2020-Q3
2020-08-20 Kvartalsrapport 2020-Q2
2020-06-26 Ordinarie utdelning DIGN 0.00 SEK
2020-06-25 Årsstämma 2020
2020-05-28 Kvartalsrapport 2020-Q1
2020-02-25 Bokslutskommuniké 2019
2020-02-10 Extra Bolagsstämma 2019
2019-11-19 Kvartalsrapport 2019-Q3
2019-08-22 Kvartalsrapport 2019-Q2
2019-05-16 Ordinarie utdelning DIGN 0.00 SEK
2019-05-16 Kvartalsrapport 2019-Q1
2019-05-15 Årsstämma 2019
2019-02-26 Bokslutskommuniké 2018
2018-11-27 Kvartalsrapport 2018-Q3
2018-08-21 Kvartalsrapport 2018-Q2
2018-05-22 Kvartalsrapport 2018-Q1
2018-04-27 Ordinarie utdelning DIGN 0.00 SEK
2018-04-26 Årsstämma 2018
2018-02-22 Bokslutskommuniké 2017
2017-12-04 Extra Bolagsstämma 2017
2017-11-23 Kvartalsrapport 2017-Q3
2017-08-24 Kvartalsrapport 2017-Q2
2017-06-02 Årsstämma 2017
2017-05-24 Kvartalsrapport 2017-Q1
2017-02-23 Bokslutskommuniké 2016
2016-11-24 Kvartalsrapport 2016-Q3
2016-08-25 Kvartalsrapport 2016-Q2
2016-05-25 Kvartalsrapport 2016-Q1
2016-03-23 Ordinarie utdelning DIGN 0.00 SEK
2016-03-22 Årsstämma 2016
2016-02-24 Bokslutskommuniké 2015
2015-11-25 Kvartalsrapport 2015-Q3
2015-08-26 Kvartalsrapport 2015-Q2
2015-05-27 Kvartalsrapport 2015-Q1
2015-05-19 Ordinarie utdelning DIGN 0.00 SEK
2015-02-24 Bokslutskommuniké 2014
2014-11-25 Kvartalsrapport 2014-Q3
2014-08-26 Kvartalsrapport 2014-Q2
2014-05-20 Kvartalsrapport 2014-Q1
2014-05-19 Ordinarie utdelning DIGN 0.00 SEK
2014-05-16 Årsstämma 2014
2014-03-04 Extra Bolagsstämma 2014
2014-02-27 Bokslutskommuniké 2013
2013-11-28 Kvartalsrapport 2013-Q3
2013-08-28 Kvartalsrapport 2013-Q2
2013-08-28 Extra Bolagsstämma 2013
2013-05-22 Kvartalsrapport 2013-Q1
2013-05-22 Ordinarie utdelning DIGN 0.00 SEK
2013-05-21 Årsstämma 2013
2013-02-27 Bokslutskommuniké 2012
2012-11-28 Kvartalsrapport 2012-Q3
2012-10-30 Extra Bolagsstämma 2012
2012-09-28 Kapitalmarknadsdag 2012
2012-08-28 Kvartalsrapport 2012-Q2
2012-06-29 Årsstämma 2012
2012-05-28 Kvartalsrapport 2012-Q1
2012-02-27 Bokslutskommuniké 2011
2011-11-17 Kvartalsrapport 2011-Q3
2011-08-22 Kvartalsrapport 2011-Q2
2011-06-13 Ordinarie utdelning DIGN 0.00 SEK
2011-06-10 Årsstämma 2011
2011-05-30 Kvartalsrapport 2011-Q1
2011-02-25 Bokslutskommuniké 2010
2010-11-18 Kvartalsrapport 2010-Q3
2010-08-19 Kvartalsrapport 2010-Q2
2010-06-21 Ordinarie utdelning DIGN 0.00 SEK
2010-05-18 Kvartalsrapport 2010-Q1
2010-02-18 Bokslutskommuniké 2009
2009-12-21 Split DIGN 100:1
2009-11-18 Kvartalsrapport 2009-Q3

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Dignitana är verksamt inom medicinteknik. Bolaget utvecklar, tillverkar och marknadsför medicinska hjälpmedel som primärt används som skalpkylningssystem vid cytostatikabehandling, vars syfte är att eliminera eller kraftigt reducera håravfall. Bolaget har global verksamhet främst inom Norden, Europa, Nordamerika och Asien. Dignitana grundades år 2007 och har sitt huvudkontor i Lund.
2021-09-30 09:00:00

Join the Conversation as Breast Cancer Survivors Share Personal Stories about Keeping their Hair During Chemotherapy

Dignitana, world leader in scalp cooling innovation, has appointed Melanie Waxler - Tampa, Florida TV reporter/anchor, author, law enforcement spokeswoman, and mother of two - as a DigniCap Dignitary, the company's patient advocacy and ambassador program.

Ms. Waxler, author of "Muse," was working on her doctorate and her second book when she was diagnosed with breast cancer-during the pandemic.  Instead of putting her life on hold, she faced breast cancer head-on, with confidence and a sense of control and gratitude. Not losing her hair during chemotherapy was an important part of the journey. Daily connection with family, colleagues and her community gave her support and strength. Her powerful story is an inspiration to anyone familiar with the words "you have cancer." See more of Melanie's personal story in this video (https://youtu.be/PDrdC79WwqA  ).

"When cancer happened to me, I didn't know what to do or where to turn," Melanie Waxler says. "I'll never forget that feeling, and I want to be there for other women who might be feeling the same. My hope is that when others hear my story, they'll feel less alone or confused. Cancer can make life seem suddenly so out of control."

In recognition of Breast Cancer Awareness Month, Ms. Waxler will host a weekly interview series on Facebook Live featuring a different breast cancer survivor every week throughout October. In candid conversations, the women - each of whom will be designated as a DigniCap Dignitary herself - will reveal personal experiences related to their cancer diagnoses and treatments. The role body image plays in personal health and workplace confidence among colleagues and supervisors will also be explored in the series. These up-close and personal interviews will be available on the DigniCap Facebook page (http://facebook.com/dignicap). 

"Putting patients first is a priority for Dignitana, and we are honored to recognize these inspirational patient stories through the DigniCap Dignitary program," said William Cronin, Chief Executive Officer of Dignitana. "Their remarkable journeys and experiences provide valuable insights to others facing the life-altering challenges brought on by a cancer diagnosis."

Now in its fifth year, the DigniCap Dignitary program is an ever-expanding group of individuals who have used The DigniCap Scalp Cooling System to reduce chemotherapy-induced alopecia associated with their prescribed cancer treatment. Receiving a cancer diagnosis can be a devastating experience, and studies show that for many, the prospect of hair loss from chemotherapy can be equally terrifying. Fortunately, more than 250 cancer centers in 38 states across the U.S. now offer their patients DigniCap, an FDA-cleared treatment that minimizes hair loss from chemotherapy.

Dignitana's Facebook Live interview series presents a unique opportunity to learn about the benefits of medical scalp cooling following the schedule below:
  • Thursday, October 7 at 1:00 p.m. EDT - Audra Byrne of Parker, Colorado
  • Thursday, October 14 at 1:00 p.m. EDT - Carla Thomas Cavalier of Los Angeles, California
  • Thursday, October 21 at 1:00 p.m. EDT - Nikki Cox of Pittsburgh, Pennsylvania
  • Thursday, October 28 at 1:00 p.m. EDT - Maricel Otero of Orlando, Florida

All interviews will be recorded with content available immediately following the presentation on the DigniCap Facebook page (https://kingcompr-my.sharepoint.com/personal/tom_tauchert_kingcompr_com/Documents/Attachments/facebook.com/dignicap).

In addition to their Facebook Live Interviews with Melanie Waxler, each DigniCap Dignitary will offer support to others and provide updates on the latest technology and reimbursement options to cancer patients in their home communities and nationwide throughout the year.